InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by BISCHOFBERGER NORBERT W, Chairman & CEO. Officer active across 1 companies, notably Kronos Bio, Inc.. Cumulatively, 3 disclosures have been published. Total volume traded: €637k. The latest transaction was disclosed on 17 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€330,42790,931 shares@ €3.633851.8% of flow
Common Stock
SEC:0001209191-22-030688:0·
Ideal exit: 11 Feb 2023 (T+270)
€153,46814,356 shares@ €10.6901100.0% of flow
Common Stock
SEC:0001209191-21-068594·
Ideal exit: 2 Sept 2022 (T+270)
€153,46814,356 shares@ €10.690124.1% of flow
Common Stock
SEC:0001209191-21-068594:0·
Ideal exit: 2 Sept 2022 (T+270)
3 of 3 declarations
About BISCHOFBERGER NORBERT W
Norbert W. Bischofberger is the Chairman & CEO of Kronos Bio, Inc. He leads the company with a strategic vision focused on innovation in the biotechnology sector. His role involves overseeing operations and developing new initiatives to strengthen the company's market position. Bischofberger brings valuable expertise and informed leadership to the executive team.
